Literature DB >> 16773684

OCTNs: will the real IBD5 gene please stand up?

Mark-S Silverberg1.   

Abstract

Crohn's disease and ulcerative colitis are inflammatory disorders of the gastrointestinal tract with a substantial heritable component. The IBD5 region on chromosome 5q31 is one of only two loci widely confirmed to be associated with Crohn's disease in multiple independent cohorts. Although many populations have demonstrated association with IBD5, there remains uncertainty as to the causal variant within the region. A recent report identified polymorphisms in SLC22A4 (OCTN1) and SLC22A5 (OCTN2) as being responsible for the IBD5 association, however, these findings have not been replicated. This review discusses the data evaluating the IBD5 locus and the OCTN genes and their relationship to inflammatory bowel disease. Several other genes, including IRF1 and P4HA2 may be equally as likely to contain the IBD5 causal variant as the OCTN genes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16773684      PMCID: PMC4087460          DOI: 10.3748/wjg.v12.i23.3678

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

1.  Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease.

Authors:  Muddassar M Mirza; Sheila A Fisher; Kathy King; Andrew P Cuthbert; Jochen Hampe; Jeremy Sanderson; John Mansfield; Peter Donaldson; Andrew J S Macpherson; Alastair Forbes; Stefan Schreiber; Cathryn M Lewis; Christopher G Mathew
Journal:  Am J Hum Genet       Date:  2003-03-03       Impact factor: 11.025

2.  Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease.

Authors:  Keiko Yamazaki; Masakazu Takazoe; Torao Tanaka; Toshiki Ichimori; Susumu Saito; Aritoshi Iida; Yoshihiro Onouchi; Akira Hata; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2004-10-19       Impact factor: 3.172

3.  Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis.

Authors:  O Palmieri; A Latiano; R Valvano; R D'Incà; M Vecchi; G C Sturniolo; S Saibeni; F Peyvandi; F Bossa; C Zagaria; A Andriulli; M Devoto; V Annese
Journal:  Aliment Pharmacol Ther       Date:  2006-02-15       Impact factor: 8.171

4.  Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup.

Authors:  E A Vasiliauskas; S E Plevy; C J Landers; S W Binder; D M Ferguson; H Yang; J I Rotter; A Vidrich; S R Targan
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

5.  A genome-wide search identifies potential new susceptibility loci for Crohn's disease.

Authors:  Y Ma; J D Ohmen; Z Li; L G Bentley; C McElree; S Pressman; S R Targan; N Fischel-Ghodsian; J I Rotter; H Yang
Journal:  Inflamm Bowel Dis       Date:  1999-11       Impact factor: 5.325

6.  Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease.

Authors:  H-P Török; J Glas; L Tonenchi; P Lohse; B Müller-Myhsok; O Limbersky; C Neugebauer; F Schnitzler; J Seiderer; C Tillack; S Brand; G Brünnler; P Jagiello; J T Epplen; T Griga; W Klein; U Schiemann; M Folwaczny; T Ochsenkühn; C Folwaczny
Journal:  Gut       Date:  2005-06-14       Impact factor: 23.059

7.  Mapping of a susceptibility locus for Crohn's disease on chromosome 16.

Authors:  J P Hugot; P Laurent-Puig; C Gower-Rousseau; J M Olson; J C Lee; L Beaugerie; I Naom; J L Dupas; A Van Gossum; M Orholm; C Bonaiti-Pellie; J Weissenbach; C G Mathew; J E Lennard-Jones; A Cortot; J F Colombel; G Thomas
Journal:  Nature       Date:  1996-02-29       Impact factor: 49.962

8.  Contribution of IBD5 locus to clinical features of IBD patients.

Authors:  Anna Latiano; O Palmieri; Rossella M Valvano; Renata D'Incà; Maurizio Vecchi; Angelo Ferraris; Giacomo C Sturniolo; Luisa Spina; Giovanni Lombardi; Bruno Dallapiccola; Angelo Andriulli; Marcella Devoto; Vito Annese
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

9.  Lack of common NOD2 variants in Japanese patients with Crohn's disease.

Authors:  Nagamu Inoue; Kazuo Tamura; Yoshitaka Kinouchi; Yoshihiro Fukuda; Seiichi Takahashi; Yasunori Ogura; Naohiro Inohara; Gabriel Núñez; Yusuke Kishi; Yuji Koike; Tooru Shimosegawa; Takashi Shimoyama; Toshifumi Hibi
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

10.  Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease.

Authors:  R K Russell; H E Drummond; E R Nimmo; N H Anderson; C L Noble; D C Wilson; P M Gillett; P McGrogan; K Hassan; L T Weaver; W M Bisset; G Mahdi; J Satsangi
Journal:  Gut       Date:  2006-02-09       Impact factor: 23.059

View more
  9 in total

1.  No association of the cytotoxic T-lymphocyte associated gene CTLA4 +49A/G polymorphisms with Crohn's disease and ulcerative colitis in Hungarian population samples.

Authors:  Lili Magyari; Bernadett Faragó; Judit Bene; Katalin Horvatovich; Lilla Lakner; Márta Varga; Mária Figler; Beáta Gasztonyi; Gyula Mózsik; Béla Melegh
Journal:  World J Gastroenterol       Date:  2007-04-21       Impact factor: 5.742

Review 2.  Role of genetics in the diagnosis and prognosis of Crohn's disease.

Authors:  Epameinondas V Tsianos; Konstantinos H Katsanos; Vasileios E Tsianos
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

3.  Selective regulation of cardiac organic cation transporter novel type 2 (OCTN2) in dilated cardiomyopathy.

Authors:  Markus Grube; Sabine Ameling; Michel Noutsias; Kathleen Köck; Ivonne Triebel; Karina Bonitz; Konrad Meissner; Gabriele Jedlitschky; Lars R Herda; Markus Reinthaler; Maria Rohde; Wolfgang Hoffmann; Uwe Kühl; Heinz-Peter Schultheiss; Uwe Völker; Stephan B Felix; Karin Klingel; Reinhard Kandolf; Heyo K Kroemer
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

4.  Prevalence of SLC22A4 1672T and SLC22A5 -207C combination defined TC haplotype in Hungarian ulcerative colitis patients.

Authors:  Lili Magyari; Judit Bene; Katalin Komlósi; Gábor Talián; Bernadett Faragó; Veronika Csöngei; Luca Járomi; Enikô Sáfrány; Csilla Sipeky; Lilla Lakner; Márta Varga; Beáta Gasztonyi; Béla Melegh
Journal:  Pathol Oncol Res       Date:  2007-03-27       Impact factor: 3.201

Review 5.  Human genetic factors and respiratory syncytial virus disease severity.

Authors:  Isao Miyairi; John P DeVincenzo
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

6.  Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn's disease in Japanese patients.

Authors:  Keiko Yamazaki; Yoshihiro Onouchi; Masakazu Takazoe; Michiaki Kubo; Yusuke Nakamura; Akira Hata
Journal:  J Hum Genet       Date:  2007-05-30       Impact factor: 3.172

7.  Detecting genome-wide directional effects of transcription factor binding on polygenic disease risk.

Authors:  Yakir A Reshef; Hilary K Finucane; David R Kelley; Alexander Gusev; Dylan Kotliar; Jacob C Ulirsch; Farhad Hormozdiari; Joseph Nasser; Luke O'Connor; Bryce van de Geijn; Po-Ru Loh; Sharon R Grossman; Gaurav Bhatia; Steven Gazal; Pier Francesco Palamara; Luca Pinello; Nick Patterson; Ryan P Adams; Alkes L Price
Journal:  Nat Genet       Date:  2018-09-03       Impact factor: 38.330

Review 8.  Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications.

Authors:  Hermann Koepsell; Katrin Lips; Christopher Volk
Journal:  Pharm Res       Date:  2007-05-01       Impact factor: 4.580

9.  The 5q31 variants associated with psoriasis and Crohn's disease are distinct.

Authors:  Yonghong Li; Monica Chang; Steven J Schrodi; Kristina P Callis-Duffin; Nori Matsunami; Daniel Civello; Nam Bui; Joseph J Catanese; Mark F Leppert; Gerald G Krueger; Ann B Begovich
Journal:  Hum Mol Genet       Date:  2008-07-09       Impact factor: 6.150

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.